News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
282,933 Results
Type
Article (17583)
Company Profile (39)
Press Release (265309)
Multimedia
Podcasts (24)
Webinars (5)
Section
Business (81669)
Career Advice (583)
Deals (14440)
Drug Delivery (34)
Drug Development (34320)
Employer Resources (40)
FDA (6238)
Job Trends (6284)
News (135495)
Policy (10309)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Standard (2)
Academia (771)
Accelerated approval (25)
Adcomms (7)
Allergies (87)
Alliances (14503)
ALS (99)
Alzheimer's disease (704)
Antibody-drug conjugate (ADC) (245)
Approvals (6648)
Artificial intelligence (335)
Autoimmune disease (177)
Automation (28)
Bankruptcy (116)
Best Places to Work (4791)
BIOSECURE Act (2)
Biosimilars (125)
Biotechnology (24)
Bladder cancer (148)
Brain cancer (43)
Breast cancer (484)
Cancer (3358)
Cardiovascular disease (293)
Career advice (483)
Career pathing (8)
CAR-T (151)
CDC (10)
Celiac Disease (2)
Cell therapy (466)
Cervical cancer (28)
Clinical research (32288)
Collaboration (1066)
Company closure (3)
Compensation (682)
Complete response letters (27)
COVID-19 (957)
CRISPR (59)
C-suite (543)
Cystic fibrosis (75)
Data (4903)
Decentralized trials (2)
Denatured (5)
Depression (76)
Dermatology (54)
Diabetes (273)
Diagnostics (2517)
Digital health (27)
Diversity (3)
Diversity, equity & inclusion (11)
Drug discovery (166)
Drug pricing (77)
Drug shortages (10)
Duchenne muscular dystrophy (146)
Earnings (53069)
Editorial (21)
Employer branding (7)
Employer resources (35)
Events (47051)
Executive appointments (568)
FDA (8351)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (10)
Frontotemporal dementia (17)
Funding (891)
Gene editing (122)
Generative AI (20)
Gene therapy (357)
GLP-1 (548)
Government (1417)
Grass and pollen (5)
Guidances (363)
Healthcare (6747)
HIV (53)
Huntington's disease (23)
IgA nephropathy (64)
Immunology and inflammation (138)
Immuno-oncology (48)
Indications (102)
Infectious disease (1128)
Inflammatory bowel disease (103)
Inflation Reduction Act (9)
Influenza (62)
Intellectual property (109)
Interviews (112)
IPO (8044)
IRA (16)
Job creations (1763)
Job search strategy (411)
JPM (27)
Kidney cancer (10)
Labor market (43)
Layoffs (200)
Leadership (7)
Legal (2184)
Liver cancer (51)
Longevity (8)
Lung cancer (499)
Lymphoma (260)
Machine learning (30)
Management (12)
Manufacturing (445)
MASH (111)
Medical device (4988)
Medtech (5053)
Mergers & acquisitions (7086)
Metabolic disorders (728)
mRNA (76)
Multiple sclerosis (109)
NASH (10)
Neurodegenerative disease (213)
Neuropsychiatric disorders (55)
Neuroscience (1503)
Neurotech (1)
NextGen: Class of 2026 (2377)
Non-profit (1603)
Now hiring (16)
Obesity (324)
Opinion (81)
Ovarian cancer (117)
Pain (108)
Pancreatic cancer (132)
Parkinson's disease (189)
Partnered (12)
Patents (200)
Patient recruitment (326)
Peanut (26)
People (17017)
Pharmaceutical (9)
Pharmacy benefit managers (11)
Phase 1 (8924)
Phase 2 (14143)
Phase 3 (11999)
Pipeline (5815)
Policy (78)
Postmarket research (1073)
Preclinical (3064)
Press Release (44)
Prostate cancer (192)
Psychedelics (12)
Radiopharmaceuticals (122)
Rare diseases (557)
Real estate (2146)
Recruiting (14)
Regulatory (9128)
Reports (24)
Research institute (719)
Resumes & cover letters (117)
Rett syndrome (37)
RNA editing (10)
RSV (50)
Schizophrenia (93)
Series A (129)
Series B (106)
Service/supplier (5)
Sickle cell disease (55)
Special edition (12)
Spinal muscular atrophy (79)
Sponsored (16)
Startups (1255)
Stomach cancer (3)
Supply chain (55)
Tariffs (36)
The Weekly (18)
Vaccines (438)
Venture capital (43)
Weight loss (237)
Women's health (54)
Worklife (3)
Date
Today (70)
Last 7 days (355)
Last 30 days (2042)
Last 365 days (16445)
2026 (7338)
2025 (16821)
2024 (15104)
2023 (15017)
2022 (18874)
2021 (20131)
2020 (17968)
2019 (15529)
2018 (11806)
2017 (10742)
2016 (11549)
2015 (44338)
2014 (19413)
2013 (5930)
2012 (6496)
2011 (7322)
2010 (6288)
Location
Africa (375)
Alabama (30)
Alaska (3)
Arizona (104)
Arkansas (4)
Asia (17175)
Australia (2765)
California (7525)
Canada (1832)
China (657)
Colorado (308)
Connecticut (368)
Delaware (286)
Europe (41981)
Florida (872)
Georgia (188)
Hawaii (3)
Idaho (21)
Illinois (616)
India (50)
Indiana (368)
Iowa (11)
Japan (378)
Kansas (48)
Kentucky (19)
Louisiana (28)
Maine (40)
Maryland (756)
Massachusetts (5409)
Michigan (218)
Minnesota (322)
Mississippi (4)
Missouri (101)
Montana (11)
Nebraska (6)
Nevada (90)
New Hampshire (32)
New Jersey (2183)
New Mexico (6)
New York (1790)
North Carolina (812)
North Dakota (4)
Northern California (3819)
Ohio (190)
Oklahoma (7)
Oregon (15)
Pennsylvania (1222)
Puerto Rico (8)
Rhode Island (11)
South America (473)
South Carolina (19)
Southern California (2929)
Tennessee (125)
Texas (1186)
United States (25540)
Utah (195)
Virginia (162)
Washington D.C. (32)
Washington State (591)
West Virginia (3)
Wisconsin (109)
282,933 Results for "15".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NeoGenomics to Participate in Upcoming Investor Conferences - May 15, 2026
May 17, 2026
·
1 min read
Press Releases
Optimi Health Announces Closing of Oversubscribed US$15 Million Public Offering
May 21, 2026
·
5 min read
Press Releases
4DMT Announces New Employment Inducement Grants - May 15, 2026
May 17, 2026
·
2 min read
Press Releases
Cormedix Therapeutics to Participate in two Upcoming Investor Conferences - May 15, 2026
May 15, 2026
·
1 min read
Press Releases
Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026
May 11, 2026
·
6 min read
Press Releases
Solana Company Reports First Quarter 2026 Financial Results - May 15, 2026
May 17, 2026
·
8 min read
Press Releases
Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants
May 20, 2026
·
3 min read
Press Releases
Solana Company to Release First Quarter 2026 Operating Results on May 15, 2026
May 11, 2026
·
1 min read
Business
BMS, Hengrui build 13-asset pipeline in $15B+ onco-immune deal
Of the 13 programs that the companies will advance, four will come from Hengrui Pharma and four from Bristol Myers Squibb. The remaining five assets will be jointly discovered.
May 12, 2026
·
2 min read
·
Tristan Manalac
Press Releases
GENFIT Annual Combined General Meeting of June 15, 2026 — Availability of Preparatory Documents
May 11, 2026
·
5 min read
1 of 28,294
Next
